Los puntos clave no están disponibles para este artículo en este momento.
Current use of hormone replacement therapy was associated with a higher risk of venous thromboembolism, although the risk seemed to be restricted to the first year of use.
Perez‐Gutthann et al. (Sat,) studied this question.